218 related articles for article (PubMed ID: 29272035)
21. Subcutaneous versus intravenous immunoglobulin for chronic autoimmune neuropathies: A meta-analysis.
Racosta JM; Sposato LA; Kimpinski K
Muscle Nerve; 2017 Jun; 55(6):802-809. PubMed ID: 27649063
[TBL] [Abstract][Full Text] [Related]
22. Childhood-Onset Multifocal Motor Neuropathy with IgM Antibodies to Gangliosides GM1: A Case Report with Poor Outcome.
Pro S; Ursitti F; Pruneddu GL; Di Capua M; Valeriani M
Neuropediatrics; 2021 Oct; 52(5):406-409. PubMed ID: 33511596
[TBL] [Abstract][Full Text] [Related]
23. Clinical features of CIDP with LM1-associated antibodies.
Kuwahara M; Suzuki H; Samukawa M; Hamada Y; Takada K; Kusunoki S
J Neurol Neurosurg Psychiatry; 2013 May; 84(5):573-5. PubMed ID: 23138763
[TBL] [Abstract][Full Text] [Related]
24. Current treatments of chronic immune-mediated demyelinating polyneuropathies.
Brannagan TH
Muscle Nerve; 2009 May; 39(5):563-78. PubMed ID: 19301378
[TBL] [Abstract][Full Text] [Related]
25. Treatment of immune-mediated, dysimmune neuropathies.
Finsterer J
Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
[TBL] [Abstract][Full Text] [Related]
26. Sensitivity and predictive value of anti-GM1/galactocerebroside IgM antibodies in multifocal motor neuropathy.
Nobile-Orazio E; Giannotta C; Musset L; Messina P; Léger JM
J Neurol Neurosurg Psychiatry; 2014 Jul; 85(7):754-8. PubMed ID: 23907602
[TBL] [Abstract][Full Text] [Related]
27. Intravenous immunoglobulins in patients with clinically suspected chronic immune-mediated neuropathy.
Lucke IM; Adrichem ME; Wieske L; van der Kooi AJ; Verhamme C; van Schaik IN; Eftimov F
J Neurol Sci; 2019 Feb; 397():141-145. PubMed ID: 30623818
[TBL] [Abstract][Full Text] [Related]
28. [Clinical factors relating to the presence of serum anti-GM1 and GD1b antibodies in demyelinating neuropathy--study using a multivariate analysis].
Irie S; Saito T; Kanazawa N; Ito H; Kowa H
Rinsho Shinkeigaku; 1994 May; 34(5):454-60. PubMed ID: 7924057
[TBL] [Abstract][Full Text] [Related]
29. Chronic Inflammatory Demyelinating Polyneuropathy.
Kuwabara S; Misawa S
Adv Exp Med Biol; 2019; 1190():333-343. PubMed ID: 31760654
[TBL] [Abstract][Full Text] [Related]
30. Multifocal acquired demyelinating sensory and motor neuropathy: report of a case and review of the literature.
Yang YW; Liu CH; Tsai CH; Lee CC; Jou SB
Acta Neurol Taiwan; 2004 Mar; 13(1):24-8. PubMed ID: 15315298
[TBL] [Abstract][Full Text] [Related]
31. Neurofascin-155 Immunoglobulin Subtypes: Clinicopathologic Associations and Neurologic Outcomes.
Shelly S; Klein CJ; Dyck PJB; Paul P; Mauermann ML; Berini SE; Howe B; Fryer JP; Basal E; Bakri HM; Laughlin RS; McKeon A; Pittock SJ; Mills J; Dubey D
Neurology; 2021 Dec; 97(24):e2392-e2403. PubMed ID: 34635556
[TBL] [Abstract][Full Text] [Related]
32. Mycophenolate mofetil as adjunctive therapy for MMN patients: a randomized, controlled trial.
Piepers S; Van den Berg-Vos R; Van der Pol WL; Franssen H; Wokke J; Van den Berg L
Brain; 2007 Aug; 130(Pt 8):2004-10. PubMed ID: 17626040
[TBL] [Abstract][Full Text] [Related]
33. Childhood-Onset Multifocal Motor Neuropathy With Immunoglobulin M Antibodies to Gangliosides GM1 and GM2: A Case Report and Review of the Literature.
Ishigaki H; Hiraide T; Miyagi Y; Hayashi T; Matsubayashi T; Shimoda A; Kusunoki S; Fukuda T
Pediatr Neurol; 2016 Sep; 62():51-7. PubMed ID: 27400822
[TBL] [Abstract][Full Text] [Related]
34. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
[TBL] [Abstract][Full Text] [Related]
35. Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies.
Dalakas MC
J Peripher Nerv Syst; 2012 May; 17 Suppl 2():34-9. PubMed ID: 22548621
[TBL] [Abstract][Full Text] [Related]
36. [Autoantibodies in Chronic Inflammatory Demyelinating Polyneuropathy].
Koga M
Brain Nerve; 2018 Apr; 70(4):395-403. PubMed ID: 29632287
[TBL] [Abstract][Full Text] [Related]
37. Testing for anti-glycolipid IgM antibodies in chronic immune-mediated demyelinating neuropathies.
Nobile-Orazio E; Giannotta C
J Peripher Nerv Syst; 2011 Jun; 16 Suppl 1():18-23. PubMed ID: 21696492
[TBL] [Abstract][Full Text] [Related]
38. Update on therapy of chronic immune-mediated neuropathies.
Briani C; Cocito D; Campagnolo M; Doneddu PE; Nobile-Orazio E
Neurol Sci; 2022 Dec; 43(Suppl 2):605-614. PubMed ID: 33452933
[TBL] [Abstract][Full Text] [Related]
39. IgM-gammopathy strongly favours immune treatable MMN and MADSAM over ALS.
Shelly S; Mills JR; Martinez-Thompson JM; Rofforth MM; Pittock SJ; Mandrekar J; Triplett JD; Mauermann M; Dubey D; Klein CJ
J Neurol Neurosurg Psychiatry; 2020 Mar; 91(3):324-326. PubMed ID: 31757814
[No Abstract] [Full Text] [Related]
40. How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies?
Nobile-Orazio E; Gallia F; Terenghi F; Allaria S; Giannotta C; Carpo M
J Neurol Sci; 2008 Mar; 266(1-2):156-63. PubMed ID: 17915254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
